Verrica Pharmaceuticals Inc (NASDAQ:VRCA)
| 4.02 Delayed Data As of Aug 12 |  +0.39 / +10.74%Today’s Change | 1.77 Today|||52-Week Range 14.79 | -56.11% Year-to-Date |
Largest transactions by value over
| Name | Type | Date | Shares traded | Share price | Transaction value | Since transaction |
|---|---|---|---|---|---|---|
Manning Paul B Director |  Buy | 7/05/2022 | 4,761,904 | $2.10 | $10.0M | +61.60% |
Perceptive Advisors Llc | Buy | 7/05/2022 | 1,428,571 | $2.10 | $3.0M | +61.60% |
Stalfort Sean Director | Buy | 7/05/2022 | 238,095 | $2.10 | $500.0K | +61.60% |
Manning Paul B Director | Buy | 12/02/2021 | 30,023 | $9.45 | $283.7K | -57.02% |
Manning Paul B Director | Buy | 12/03/2021 | 19,977 | $9.22 | $184.2K | -56.37% |
Goldenberg Gary Chief Medical Officer | Buy | 7/05/2022 | 23,809 | $2.10 | $50.0K | +61.60% |
White Ted President & Chief Executive Officer | Buy | 7/05/2022 | 23,809 | $2.10 | $50.0K | +61.60% |
Hayes Christopher G Chief Legal Officer | Buy | 7/11/2022 | 7,500 | $3.40 | $25.5K | +37.41% |
Hayes Christopher G Chief Legal Officer | Buy | 7/05/2022 | 5,714 | $2.10 | $12.0K | +61.60% |